← FDA DRUG APPROVALS

FDA ANDA · ANDA201961

PHENTERMINE HYDROCHLORIDE

Sponsor: LANNETT CO INC

APPLICATION
ANDA201961
TYPE
ANDA
ORIGINAL APPROVAL
2011-07-20
LATEST ACTION
2017-05-31
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued

Products

PHENTERMINE HYDROCHLORIDEDiscontinued
PHENTERMINE HYDROCHLORIDE 37.5MG · CAPSULE · ORAL

Approval history

2017-05-31Labeling · Supplement 7 · standardAP
2012-12-05Labeling · Supplement 3 · standardAP
2012-04-20Labeling · Supplement 2AP
2012-02-14Manufacturing (CMC) · Supplement 1AP
2011-07-20Not Applicable · OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →